Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Connie Marras

Showing results (11-20 of 304) with videos related to

Pageof 31
Sort By:
Journal of Parkinson'S Disease|June 6, 2022
Epidemiological Evidence for an Immune Component of Parkinson's DiseasePaulina Gonzalez-Latapi, Connie Marras
Parkinsonism & Related Disorders|March 21, 2015
Telemedicine in Parkinson's disease: A patient perspective at a tertiary care centreJudy K Qiang, Connie Marras
Movement Disorders : Official Journal of the Movement Disorder Society|March 13, 2015
Orthostatic hypotension in Parkinsonism: What is it and how can we treat it?Susan H Fox, Connie Marras
Expert Review of Neurotherapeutics|April 28, 2005
Outcome measures for clinical trials in Parkinson's disease: achievements and shortcomingsConnie Marras, Antony E Lang
Nature Reviews. Neurology|February 22, 2019
Clinical Parkinson disease subtyping does not predict pathologyAlberto J Espay, Connie Marras
Movement Disorders : Official Journal of the Movement Disorder Society|January 18, 2019
We are what we eat - editors' note on the role of diet in Parkinson's diseaseConnie Marras, Jose A Obeso
Nature Reviews. Neurology|May 4, 2019
Reply to 'Neuropathological progression of clinical Parkinson disease subtypes'Alberto J Espay, Connie Marras
Seminars in Neurology|January 24, 2012
Genetics meets environment: evaluating gene-environment interactions in neurologic diseasesConnie Marras, Samuel M Goldman
Movement Disorders : Official Journal of the Movement Disorder Society|May 3, 2014
The complexities of hormonal influences and risk of Parkinson's diseaseConnie Marras, Rachel Saunders-Pullman
Lancet (London, England)|June 15, 2014
Initiating dopaminergic treatment in Parkinson's diseaseAnthony E Lang, Connie Marras
Pageof 31

Showing results (11-20 of 304) with videos related to

Sort By:
Pageof 31
Journal of Parkinson'S Disease|June 6, 2022
Epidemiological Evidence for an Immune Component of Parkinson's DiseasePaulina Gonzalez-Latapi, Connie Marras
Parkinsonism & Related Disorders|March 21, 2015
Telemedicine in Parkinson's disease: A patient perspective at a tertiary care centreJudy K Qiang, Connie Marras
Movement Disorders : Official Journal of the Movement Disorder Society|March 13, 2015
Orthostatic hypotension in Parkinsonism: What is it and how can we treat it?Susan H Fox, Connie Marras
Expert Review of Neurotherapeutics|April 28, 2005
Outcome measures for clinical trials in Parkinson's disease: achievements and shortcomingsConnie Marras, Antony E Lang
Nature Reviews. Neurology|February 22, 2019
Clinical Parkinson disease subtyping does not predict pathologyAlberto J Espay, Connie Marras
Movement Disorders : Official Journal of the Movement Disorder Society|January 18, 2019
We are what we eat - editors' note on the role of diet in Parkinson's diseaseConnie Marras, Jose A Obeso
Nature Reviews. Neurology|May 4, 2019
Reply to 'Neuropathological progression of clinical Parkinson disease subtypes'Alberto J Espay, Connie Marras
Seminars in Neurology|January 24, 2012
Genetics meets environment: evaluating gene-environment interactions in neurologic diseasesConnie Marras, Samuel M Goldman
Movement Disorders : Official Journal of the Movement Disorder Society|May 3, 2014
The complexities of hormonal influences and risk of Parkinson's diseaseConnie Marras, Rachel Saunders-Pullman
Lancet (London, England)|June 15, 2014
Initiating dopaminergic treatment in Parkinson's diseaseAnthony E Lang, Connie Marras
Pageof 31